Unemployment, public-sector health-care spending and breast cancer mortality in the European Union: 1990-2009

European Journal of Public Health

Volumn 25, Issue 2, 2015, Pages 330-335

  Maruthappu, Mahiben ^a,b   Watkins, Johnathan A ^c   Waqar, Mueez ^d   Williams, Callum ^e,f   Ali, Raghib ^g,h   Atun, Rifat ⁱ   Faiz, Omar ^a   Zeltner, Thomas ^j,k  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b HARVARD UNIVERSITY   (United States)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

^e Economist Magazine   (United Kingdom)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g UNIVERSITY OF OXFORD   (United Kingdom)

^h UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

ⁱ HARVARD UNIVERSITY   (United States)

^j WORLD HEALTH ORGANIZATION   (Switzerland)

^k UNIVERSITY OF BERN   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BREAST TUMOR; ECONOMICS; EUROPEAN UNION; FEMALE; HEALTH CARE COST; HEALTH CARE DELIVERY; HUMAN; MORTALITY; ORGANIZATION AND MANAGEMENT; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; UNEMPLOYMENT;

BREAST NEOPLASMS; DELIVERY OF HEALTH CARE; EUROPEAN UNION; FEMALE; HEALTH EXPENDITURES; HUMANS; PUBLIC SECTOR; SURVIVAL RATE; UNEMPLOYMENT;

EID: 84926628534     PISSN: 11011262     EISSN: 1464360X     Source Type: Journal    
DOI: 10.1093/eurpub/cku167     Document Type: Article

References (39)

1. Horton R. The global financial crisis: an acute threat to health. Lancet 2009;373: 355-6.
2. Stuckler D, Basu S. The Body Economic: Why Austerity Kills. New York City, USA: Basic Books, 2013.
3. Paul K, Moser K. Unemployment impairs mental health: meta-analyses. J Vocational Behav 2009;74:264-82.
4. Morris J, Cook D, Shaper G. Loss of employment and mortality. BMJ 1994;308: 1135-9.
5. Ungváry G, Morvai V, Nagy I. Health risk of unemployment. Central Eur JOEM 1999;5:91-112.
6. Reeves A, McKee M, Basu S, Stuckler D. The political economy of austerity and healthcare: Cross-national analysis of expenditure changes in European nations 1995-2011. Health Policy 2014;115:1-8.
7. Barr B, Taylor-Robinson D, Scott-Samuel A, et al. Suicides associated with the 2008-10 economic recession in England: time trend analysis. BMJ 2012;345: e5142.
8. Stuckler D, Basu S, Suhrcke M, et al. The public health effect of economic crises and alternative policy responses in Europe: an empirical analysis. Lancet 2009;374: 315-23.
9. Stuckler D, Basu S, Suhrcke M, McKee M. The health implications of financial crisis: a review of the evidence. Ulster Med J 2009;78:142-5.
10. Tapia-Granados JA. Increasing mortality during the expansions of the US economy, 1900-1996. Int J Epidemiol 2005;34:1194-202.
11. Gerdtham U-G, Ruhm CJ. Deaths rise in good economic times: evidence from the OECD. Econ Hum Biol 2006;4:298-316.
12. Malvezzi M, Bertuccio P, Levi F, et al. European cancer mortality predictions for the year 2013. Ann Oncol 2013;24:792-800.
13. Klein-Hesselink DJ, Spruit IP. The contribution of unemployment to socioeconomic health differences. Int J Epidemiol 1992;21:329-37.
14. Rutherford MJ, Hinchliffe SR, Abel GA, et al. How much of the deprivation gap in cancer survival can be explained by variation in stage at diagnosis: an example from breast cancer in the East of England. Int J Cancer 2013;133: 2192-200.
15. Akinyemiju TF, Soliman AS, Copeland G, et al. Trends in breast cancer stage and mortality in Michigan (1992-2009) by race, socioeconomic status and area healthcare resources. PLoS One 2013;8:e61879.
16. Weissman JS, Stern R, Fielding SL, Epstein AM. Delayed access to health care: risk factors, reasons, and consequences. Ann Intern Med 1991;114: 325-31.
17. Adams J, White M, Forman D. Are there socioeconomic gradients in stage and grade of breast cancer at diagnosis? Cross sectional analysis of UK cancer registry data. BMJ 2004;329:142.
18. World Health Organization. Mortality database. World Health Organization, 2013. Available at: http://apps.who.int/healthinfo/statistics/mortality/whodpms (26 December 2013, date last accessed).
19. Mathers CD, Fat DM, Inoue M, et al. Counting the dead and what they died from: an assessment of the global status of cause of death data. Bull World Health Organ 2005;83:171-7.
20. World Bank. Development Indicators & Global Development Finance 2013. World Bank, 2013. Available at: http://data.worldbank.org/data-catalog/worlddevelopment-indicators (26 December 2013, date last accessed).
21. International Monetary Fund. Historical Public Debt Database. International Monetary Fund, 2013. Available at: http://www.imf.org/external/pubs/ft/wp/2010/ wp10245.pdf (26 December 2013, date last accessed).
22. Cook RD, Weisberg S. Diagnostics for heteroscedasticity in regression. Biometrika 1983;70:1-10.
23. Davidson R, MacKinnon J. Estimation and Inference in Econometrics. New York City, USA: Oxford University Press, USA, 1993.
24. Saffer H, Chaloupka F. The effect of tobacco advertising bans on tobacco consumption. J Health Econ 2000;19:1117-37.
25. European Commission. EUROSTAT. European Commission, 2013. Available at: epp.eurostat.ec.europa.eu (26 December 2013, date last accessed).
26. International Agency for Research on Cancer. EUREG European Cancer Registry. Lyon, France: International Agency for Research on Cancer, 2013. Available at: http://eco.iarc.fr/EUREG/Default.aspx (26 December 2013, date last accessed).
27. Bradley CJ, Given CW, Roberts C. Race, socioeconomic status, breast cancer treatment and survival. J Natl Cancer Inst 2002;94:490-6.
28. Dasgupta P, Baade PD, Aitken JF, Turrell G. Multilevel determinants of breast cancer survival: association with geographic remoteness and area-level socioeconomic disadvantage. Breast Cancer Res Treat 2012;132:701-10.
29. Lyratzopoulos G, Barbiere JM, Rachet B, et al. Changes over time in socioeconomic inequalities in breast and rectal cancer survival in England and Wales during a 32-year period (1973-2004): the potential role of health care. Ann Oncol 2011;22:1661-6.
30. Ades F, Senterre C, de Azambuja E, et al. Discrepancies in cancer incidence and mortality and its relationship to health expenditure in the European Union member states. Ann Oncol 2013;24:2897-902.
31. 16-year Mortality from breast cancer in the UK Trial of Early Detection of Breast Cancer. Lancet 1999;353:1909-14.
32. Davies C, Godwin J, Gray R, et al. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet 2011;378:771-84.
33. Slamon D, Eiermann W, Robert N, et al. Adjuvant trastuzumab in HER2-positive breast cancer. N Engl J Med 2011;365:1273-83.
34. Baselga J, Cortés J, Kim SB, et al. Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer. N Engl J Med 2012;366:109-19.
35. Office for Budget Responsibility. Economic and Fiscal Outlook. London, UK: Office for Budget Responsibility, 2011.
36. Ball L, Leigh D, Loungani P. Painful medicine. Finance Dev 2011;48:20-3.
37. Baily MN. Europe's So-called "Expansionary Contraction" Has Not Worked in Practice. Brookings Institution, 2012, Available at: http://www.brookings.edu/ research/opinions/2012/02/expansionary-contraction-baily (9 March 2014, date last accessed).
38. Perotti R. The "Austerity Myth": gain without pain? In: Alesina A, Giavazzi F, editors. Fiscal Policy after the Financial Crisis Chicago, USA: University of Chicago Press, 2013.
39. Sugawara N. Fiscal adjustment in Greece under the financial rescue programme: the distributional effects on Greek households. Appl Econ Lett 2012;19:1071-4.